---
document_datetime: 2025-10-06 13:33:54
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/imlygic-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: imlygic-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 4.726388
conversion_datetime: 2025-12-27 16:27:27.94291
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Imlygic

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproductlifecycleprocedures,youmayneed to alsorefer toEPAR-Procedural steps taken and scientific information after authorisation (archive).

| Applicationnumber   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|---------------------|----------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Variation type IA / | This was an application for a group of | 06/10/2025                          |                                          | Annex II                        |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000296281                     | variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|---------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                       | A.5Changeinthename and/oraddressof a manufacturer/importerofthefinished product (including batch release or quality control testing sites)-A.5.bThe activities for which the manufacturer/importer is responsible do not include batch release - Accepted A.ADMINISTRATIVE CHANGES- A.4 Change in thename and/or addressof:a manufacturer(includingwhererelevant quality control testing sites); or an ASMF holder; or a supplier of the active substance, startingmaterial,reagentorintermediate used in themanufacture of the active substance(where specified in the technical dossier)where noPh.Eur.Certificate of Suitabilityispartof theapproveddossier;or amanufacturerofanovelexcipient(where | A.5Changeinthename and/oraddressof a manufacturer/importerofthefinished product (including batch release or quality control testing sites)-A.5.bThe activities for which the manufacturer/importer is responsible do not include batch release - Accepted A.ADMINISTRATIVE CHANGES- A.4 Change in thename and/or addressof:a manufacturer(includingwhererelevant quality control testing sites); or an ASMF holder; or a supplier of the active substance, startingmaterial,reagentorintermediate used in themanufacture of the active substance(where specified in the technical dossier)where noPh.Eur.Certificate of Suitabilityispartof theapproveddossier;or amanufacturerofanovelexcipient(where |
| Variation type II / EMA/VR/0000258245 | B.I.a.1Change in the manufacturer of a startingmaterial/reagent/intermediateused in themanufacturingprocessof theactive substanceorchangeinthemanufacturer (includingwhererelevantqualitycontrol testing sites)of the active substance,where noPh.Eur.Certificate of Suitability is part of                                                                                                                                                                                                                                                                                                                                                                                                            | 18/09/2025                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

<div style=\"page-break-after: always\"></div>

| biological active substance: replacement or addition of a site where batch control/testing including a biological / immunological / immunochemicalmethodtakesplace- Accepted   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|